Low-quality muscle mass rather than normal-quality muscle mass determines fibrosis progression in biopsy-proven NAFLD.
Yun Kyu LeeBo Kyung KooSae Kyung JooDong Hyeon LeeHeejoon JangJee Won ChaiMyoung Seok LeeSi Won JangYoung Ho SoJeong Hwan ParkMee Soo ChangWon Kimnull nullPublished in: Alimentary pharmacology & therapeutics (2023)
Increased low-quality muscle mass, but not decreased normal-quality muscle mass, as assessed by a muscle quality map in CT, predicts fibrosis progression in patients with NAFLD.